Status:
ACTIVE_NOT_RECRUITING
Nano-Learning for Improving Compliance Among Older Adults With Sarcopenia
Lead Sponsor:
Alexandria University
Conditions:
Learning; Lack of (Specific)
Depression
Eligibility:
All Genders
58-75 years
Phase:
NA
Brief Summary
Empirical evidence suggests that the use of short videos is associated with decreased feelings of loneliness and social isolation, thereby reducing depression among older adults . Platforms that allow...
Detailed Description
Nanolearning is an innovative pedagogical strategy that delivers content in highly focused, ultra-short learning experiences, often lasting less than two minutes, aimed at teaching a single skill or t...
Eligibility Criteria
Inclusion
- Participants were eligible if they were 60 years or older,
- had a diagnosis of sarcopenia based on a cut-off score of ≥3 of the Sarcopenia Geriatric Scale (SARCO-GS) (Rosas-Carrasco, 2023),
- able to communicate effectively, and provided informed consent.
Exclusion
- Exclusion criteria encompassed severe cognitive impairment, debilitating chronic conditions, or unstable medical status that could hinder participation.
- Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), with a cutoff score of 25 or below used to exclude participants (Nasreddine, 2005).
Key Trial Info
Start Date :
September 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 25 2026
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT07185763
Start Date
September 7 2025
End Date
February 25 2026
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Nursing
Alexandria, Egypt, 21523